Could an Aurora Cannabis and Aphria Merger Actually Happen?

: ACB | Aurora Cannabis Inc. News, Ratings, and Charts

ACB – A merger for Aurora Cannabis (ACB) and Aphria (APHA) could be on the horizon.

This week, it was reported that Aurora Cannabis (ACB) and Aphria (APHA) recently held advanced talks to merge in what would have been one of the largest mergers in the cannabis sector to date. Those discussions broke down late last week, according to two people familiar with the matter.

Two sources told BNN Bloomberg Both that the companies took a step back from negotiations after failing to agree on board structure and compensation for senior-level executives. They did not know if the two companies would resume talks.

Michelle Lefler, Vice-president of Communications at ACB, told BNN Bloomberg in an email that the company’s corporate policy is “not to comment on rumors or speculation.” APHA was also silent on the matter as a spokesperson for APHA did not provide comment after multiple requests from BNN Bloomberg.

Before the negotiations came to a halt, executives came to a partial agreement that would have seen APHA shareholders control approximately 51 percent of the combined company. ACB shareholders would own the remaining 49 percent. According to one of the sources who were not familiar with the planned exchange ratio, the deal would have been conducted through a share swap. APHA CEO Irwin Simon was set to become Chief Executive Officer of the new company.

This would be a blessing for ACB shareholders because APHA is already profitable and has a better balance sheet than ACB. This might also explain why ACB is taking such a long time to announce a new CEO. My only concern with the potential merger is the massive debt that ACB still holds on its balance sheet. The details of this transaction are still under wraps as this is just a rumor right now, but as the cannabis sector continues to consolidate, this is something investors should keep in mind.

Overall, an ACB and APHA merger would make sense, and in my opinion, could be what both companies need to take the number one spot in the Canadian cannabis sector away from CGC.

Disclosure: The author is long APHA and ACB

Want More Great Investing Ideas?

9 “BUY THE DIP” Growth Stocks for 2020

Top 5 WINNING Stock Chart Patterns

7 “Safe-Haven” Dividend Stocks for Turbulent Times


ACB shares were trading at $12.17 per share on Wednesday afternoon, up $0.42 (+3.57%). Year-to-date, ACB has declined -53.05%, versus a 0.85% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
ACBGet RatingGet RatingGet Rating
APHAGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


How Bad Will 2025 Be for Stocks?

As January goes...so goes the stock market. And right now that saying bodes poorly for the year ahead. Especially for the S&P 500 (SPY). That is why Steve Reitmeister shares 2 different paths the market could take in 2025 and how to get your portfolio on the right side of the action.

3 Tech Stocks to Buy in 2025 and Hold Forever

Tech stocks soared in 2024, fueled by AI and cutting-edge innovations, but what’s next? As global IT spending surges and data-driven technologies reshape industries, its long-term prospects remain bright. Hence, fundamentally strong tech stocks Microsoft Corp. (MSFT), Alphabet Inc. (GOOGL), and Cisco Systems (CSCO) could be ideal buy-and-hold options for investors. Read more…

3 Blue-Chip Stocks with Strong Buy Ratings from Analysts

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability and long-term growth potential. Thus, one could consider adding these three fundamentally sound blue-chip stocks, AbbVie (ABBV), Merck & Co. (MRK), and Johnson & Johnson (JNJ), with Strong Buy ratings from analysts. Read more…

3 Quantum Computing Firms Pioneering the Next Tech Revolution

Quantum computing firms are transforming industries with groundbreaking advancements, a strong market presence, institutional backing, and rapid innovation, making them an attractive investment opportunity. Considering fundamentally robust quantum computing stocks like RTX Corporation (RTX), Northrop Grumman (NOC), and Nokia (NOK) could be a wise choice. Read more...

2024 Stock Market Lessons Learned

Steve Reitmeister shares his annual “Lessons Learned” edition in the hopes it improves your investing performance in the years ahead. Clearly this process works given how Steve has topped the S&P 500 (SPY) once again this year. Read on below for the full story...

Read More Stories

More Aurora Cannabis Inc. (ACB) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ACB News